Evidence map›Paper›PMID 29998398›Full record

ArticleMolecular neurobiology2019

Inhibition of the Nrf2/HO-1 Axis Suppresses the Mitochondria-Related Protection Promoted by Gastrodin in Human Neuroblastoma Cells Exposed to Paraquat.

Marcos Roberto de Oliveira, Flávia de Bittencourt Brasil, Cristina Ribas Fürstenau

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Gastrodin: a comprehensive pharmacological review.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  2. Review
  3. Review on pharmacological effects of gastrodin.Archives of pharmacal research · 2023
    Review
  4. Review
  5. Gastrodin and Vascular Dementia: Advances and Current Perspectives.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Marcos Roberto de OliveiraGrupo de Estudos em Neuroquímica e Neurobiologia de Moléculas Bioativas, Universidade Federal de Mato Grosso (UFMT), Av. Fernando Corrêa da Costa, 2367, Cuiaba, MT, 78060-900, Brazil. mrobioq@gmail.com.ORCID http://orcid.org/0000-0003-2414-6605
Flávia de Bittencourt BrasilDepartamento de Ciências da Natureza, Campus Universitário de Rio das Ostras, Universidade Federal Fluminense (UFF), Rio de Janeiro, Brazil.
Cristina Ribas FürstenauInstituto de Biotecnologia (IBTEC), Universidade Federal de Uberlândia (UFU), Patos de Minas, MG, Brazil.
Universidade Federal de Mato Grosso · BRUniversidade Federal de Uberlândia · BRUniversidade Federal Fluminense · BR

Funding

CNPq CNPq Edital Universal 2016
6 · The paper itself

Abstract

Mitochondria are double-membrane organelles involved in the transduction of energy from different metabolic substrates into adenosine triphosphate (ATP) in mammalian cells. The oxidative phosphorylation system is comprised by the activity of the respiratory chain and the complex V (ATP synthase/ATPase). This system is dependent on oxygen gas (O

Indexed as

Benzyl AlcoholsCell Line, TumorCytoprotectionGlucosidesHeme Oxygenase-1HerbicidesHumansMembrane Potential, MitochondrialMitochondriaNeuroblastomaNF-E2-Related Factor 2ParaquatReactive Oxygen SpeciesBenzyl AlcoholsgastrodinGlucosidesHeme Oxygenase-1HerbicidesHMOX1 protein, humanNFE2L2 protein, humanNF-E2-Related Factor 2ParaquatReactive Oxygen SpeciesBioenergeticsGastrodinHO-1MitochondriaNrf2Paraquat

Identifiers

PMID29998398
OpenAlexW2862431868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.